Bachleda Mark 4
4 · Galera Therapeutics, Inc. · Filed Oct 12, 2021
Insider Transaction Report
Form 4
Bachleda Mark
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-10-08+200,000→ 200,000 totalExercise: $7.84Exp: 2031-10-07→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable as to 25% on October 8, 2022, and in thirty-six (36) substantially equal monthly installments over a three year period thereafter.